132 related articles for article (PubMed ID: 8207254)
1. A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma.
Jain R; Roncella S; Hashimoto S; Carbone A; Francia di Celle P; Foa R; Ferrarini M; Chiorazzi N
J Immunol; 1994 Jul; 153(1):45-52. PubMed ID: 8207254
[TBL] [Abstract][Full Text] [Related]
2. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
[TBL] [Abstract][Full Text] [Related]
3. Burkitt's lymphomas express VH genes with a moderate number of antigen-selected somatic mutations.
Tamaru J; Hummel M; Marafioti T; Kalvelage B; Leoncini L; Minacci C; Tosi P; Wright D; Stein H
Am J Pathol; 1995 Nov; 147(5):1398-407. PubMed ID: 7485402
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of a conserved idiotope expressed by an autoreactive human B cell lymphoma. Evidence that a VH CDR3 mutation alters idiotypy and specificity.
Reidl LS; Friedman DF; Goldman J; Hardy RR; Jefferies LC; Silberstein LE
J Immunol; 1991 Nov; 147(10):3623-31. PubMed ID: 1940361
[TBL] [Abstract][Full Text] [Related]
5. Differential binding avidities of human IgM for staphylococcal protein A derive from specific germ-line VH3 gene usage.
Hakoda M; Kamatani N; Hayashimoto-Kurumada S; Silverman GJ; Yamanaka H; Terai C; Kashiwazaki S
J Immunol; 1996 Oct; 157(7):2976-81. PubMed ID: 8816405
[TBL] [Abstract][Full Text] [Related]
6. Intraclonal homogeneity of clonotypic immunoglobulin M and diversity of nonclinical post-switch isotypes in multiple myeloma: insights into the evolution of the myeloma clone.
Taylor BJ; Pittman JA; Seeberger K; Mant MJ; Reiman T; Belch AR; Pilarski LM
Clin Cancer Res; 2002 Feb; 8(2):502-13. PubMed ID: 11839670
[TBL] [Abstract][Full Text] [Related]
7. Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity.
Chapman CJ; Mockridge CI; Rowe M; Rickinson AB; Stevenson FK
Blood; 1995 Apr; 85(8):2176-81. PubMed ID: 7718888
[TBL] [Abstract][Full Text] [Related]
8. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines.
Albert T; Urlbauer B; Kohlhuber F; Hammersen B; Eick D
Oncogene; 1994 Mar; 9(3):759-63. PubMed ID: 8108117
[TBL] [Abstract][Full Text] [Related]
9. Intraclonal offspring expansion of gastric low-grade MALT-type lymphoma: evidence for the role of antigen-driven high-affinity mutation in lymphomagenesis.
Qin Y; Greiner A; Hallas C; Haedicke W; Müller-Hermelink HK
Lab Invest; 1997 Apr; 76(4):477-85. PubMed ID: 9111510
[TBL] [Abstract][Full Text] [Related]
10. Human anti-Gal heavy chain genes. Preferential use of VH3 and the presence of somatic mutations.
Wang L; Radic MZ; Galili U
J Immunol; 1995 Aug; 155(3):1276-85. PubMed ID: 7543518
[TBL] [Abstract][Full Text] [Related]
11. [Molecular analysis in Argentinian patients with Burkitt's lymphoma].
Gutiérrez MI; Barriga F; Díez B; Larripa I; Magrath I
Sangre (Barc); 1990 Feb; 35(1):10-4. PubMed ID: 2159189
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin VH gene expression among extranodal marginal zone B-cell lymphomas of the ocular adnexa.
Coupland SE; Foss HD; Anagnostopoulos I; Hummel M; Stein H
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):555-62. PubMed ID: 10067957
[TBL] [Abstract][Full Text] [Related]
13. Role of Epstein-Barr virus in the etiology of Burkitt's lymphoma.
Purtilo DT; Manolov G; Manolova Y; Harada S; Lipscomb H; Tatsumi E
IARC Sci Publ; 1985; (60):231-47. PubMed ID: 2998991
[TBL] [Abstract][Full Text] [Related]
14. Two antisense promoters in the immunoglobulin mu-switch region drive expression of c-myc in the Burkitt's lymphoma cell line BL67.
Apel TW; Mautner J; Polack A; Bornkamm GW; Eick D
Oncogene; 1992 Jul; 7(7):1267-71. PubMed ID: 1620543
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcal protein A induces biased production of Ig by VH3-expressing B lymphocytes.
Kristiansen SV; Pascual V; Lipsky PE
J Immunol; 1994 Oct; 153(7):2974-82. PubMed ID: 8089481
[TBL] [Abstract][Full Text] [Related]
16. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas.
Bhatia K; Huppi K; Spangler G; Siwarski D; Iyer R; Magrath I
Nat Genet; 1993 Sep; 5(1):56-61. PubMed ID: 8220424
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of immunoglobulin genes in primary intraocular lymphoma.
Coupland SE; Hummel M; Müller HH; Stein H
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3507-14. PubMed ID: 16186327
[TBL] [Abstract][Full Text] [Related]
18. Transchromosomally derived Ig heavy chains.
Knight KL; Kingzette M; Crane MA; Zhai SK
J Immunol; 1995 Jul; 155(2):684-91. PubMed ID: 7608545
[TBL] [Abstract][Full Text] [Related]
19. Forward and reverse changes in Ig/myc translocation carrying tumors.
Klein G
Princess Takamatsu Symp; 1989; 20():135-42. PubMed ID: 2562178
[TBL] [Abstract][Full Text] [Related]
20. HBL-3 cell line, derived from precursor B-cell lymphoblastic leukemia, lacks somatic hypermutation of immunoglobulin heavy chain variable region genes.
Hojo H; Sasaki Y; Nakamura N; Sato M; Abe M
Pediatr Dev Pathol; 2004; 7(3):250-7. PubMed ID: 15022065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
